Recent Technical Analysis Signals for ENTA - Enanta Pharmaceuticals, Inc.

Date	Name	Type	% Chg
2023-12-12	Stochastic Reached Oversold	Weakness	16.46%
2023-12-12	Down 3 Days in a Row	Weakness	16.46%
2023-12-12	Down 4 Days in a Row	Weakness	16.46%
2023-12-12	Oversold Stochastic	Weakness	16.46%
2023-12-11	MACD Bearish Centerline Cross	Bearish	15.56%
2023-12-11	MACD Bearish Signal Line Cross	Bearish	15.56%
2023-12-11	NR7	Range Contraction	15.56%
2023-12-11	Down 3 Days in a Row	Weakness	15.56%
2023-12-08	Fell Below 20 DMA	Bearish	13.19%
2023-12-08	Fell Below 50 DMA	Bearish	13.19%